SV40LTA&E1A Residue DNA Detection Kit _ 41310ES

YeasenSku: 41310ES50

Size: 50 T
Precio:
Precio de venta$955.00

Envío calculado En caja

Existencias:
En stock

Descripción

This kit is designed for the quantitative detection of residual host cell DNA—specifically SV40 Large T Antigen (LTA) and Adenovirus E1A sequences—in biopharmaceutical products derived from host cells such as HEK293T.

Utilizing probe-based real-time PCR (qPCR), the assay enables highly specific and rapid quantification of SV40 LTA and E1A residual DNA, with a limit of detection as low as 10¹ copies/μL.

The kit is fully compatible with Yeasen’s Magnetic Bead–Based Residual DNA Sample Preparation Kits (Cat# 18461ES) for streamlined sample processing.

Features

  • Complies with regulations – Fully validated; validation reports available.
  • High-quality reagents – All components in-house developed; enzymes made in ultra-clean facility.
  • Highly sensitive – Detection down to 10¹ copies/μL.
  • Highly reproducible – Low within-run and between-run variability.
  • Highly specific – Detects only SV40 LTA and E1A DNA—no cross-reactivity.
  • Built-in control – Internal Control (IC) flags sample or reaction issues.

Components

Components No.

Name

41310ES50(50 T)
41310ES60(100 T)

41310-A

SV40LTA&E1A qPCR Mix

0.75 mL

1.5 mL

41310-B

SV40LTA&E1A Primer&Probe Mix

200 μL

400 μL

41310-C

DNA Dilution Buffer

2 × 1.8 mL

4 × 1.8 mL

41310-D

SV40LTA&E1A DNA Control (nonliner)

25 μL

50 μL

41310-E

SV40LTA&E1A DNA Control (linear)

25 μL

50 μL

41310-F

IC

50 μL

100 μL

*IC: Internal control.

Storage

This product should be stored at -25~-15for 2 years. Both 41310-A and 41310-B should be stored protected from light.

Applicable Instrument Models

Include but not limited to:

Bio-Rad: CFX96 Optic Module.

Thermo Scientific: ABI 7500; ABI Quant Studio 5.

Figures

1. Detection Range

SV40LTA: Linear range = 1.8 × 10¹ ~ 1.8 × 10⁵ copies/μL, R² = 1.000, amplification efficiency = 100.25%, CV < 15% across all concentrations.

E1A: Linear range = 1.8 × 10¹ ~ 1.8 × 10⁵ copies/μL, R² = 1.000, amplification efficiency = 100.25%, CV < 15% across all concentrations.

Figure 1. SV40LTA standard curve (left) and amplification plot (right)https://www.yeasenbio.com/products/80510

 Figure 1. SV40LTA standard curve (left) and amplification plot (right)

&nbsp;Figure 2. E1A standard curve (left) and amplification plot (right)

 Figure 2. E1A standard curve (left) and amplification plot (right)

2. Limit of Quantitation (LOQ)

SV40LTA & E1A DNA at concentrations of 18, 9, 4.5, 2.25, and 1.8 copies/μL were tested in 10 replicates each. At ≥4.5 copies/μL, CVs were <20%, establishing the LOQ as 4.5 copies/μL.

Figure 3. qPCR detection of SV40LTA(lift) and E1A(right) at 4.5 copies/μL

 

Replicate

Analyte

SV40LTA (copies/μL)

E1A (copies/μL)

Quantity

Recovery

Quantity

Recovery

1

4.66

103.61%

4.87

108.21%

2

4.33

96.29%

4.15

92.26%

3

4.49

99.72%

4.63

102.88%

4

5.08

112.97%

4.86

107.99%

5

6.26

139.11%

5.67

125.93%

6

5.46

121.26%

4.97

110.42%

7

4.79

106.34%

5.50

122.22%

8

5.57

123.83%

5.00

111.20%

9

5.09

113.18%

5.55

123.28%

10

4.62

102.62%

4.97

110.43%

Mean

5.04

\

5.02

\

CV%

11.73%

\

9.13%

\

 Documents:

Safety Data Sheet

40310_MSDS_HB260203_EN.PDF

Manuals

40310_Manual_Ver.EN20260203.pdf

Pago y seguridad

American Express Apple Pay Diners Club Discover Google Pay Mastercard Visa

Su información de pago se procesa de forma segura. No almacenamos detalles de la tarjeta de crédito ni tenemos acceso a la información de su tarjeta de crédito.

Consulta

También te puede gustar

Preguntas frecuentes

El producto es solo para fines de investigación y no está destinado a uso terapéutico o diagnóstico en humanos o animales. Los productos y el contenido están protegidos por patentes, marcas comerciales y derechos de autor propiedad de Yeasen Biotechnology. Los símbolos de marca comercial indican el país de origen, no necesariamente el registro en todas las regiones.

Algunas aplicaciones pueden requerir derechos de propiedad intelectual adicionales de terceros.

Yeasen se dedica a la ciencia ética y cree que nuestra investigación debe abordar cuestiones críticas al tiempo que garantiza la seguridad y los estándares éticos.